Concorde Asset Management, LLC Lemaitre Vascular Inc Transaction History

Concorde Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 25, 2019	SELL	$22.01 - $37.23 $349,254 - $590,765	-15,868 Closed	0 $0
Q3 2018 Oct 30, 2018	SELL	$34.02 - $38.74 $181,632 - $206,832	-5,339 Reduced 25.18%	15,868 $615,000
Q2 2018 Jul 17, 2018	BUY	$31.45 - $41.02 $198,669 - $259,123	6,317 Added 42.42%	21,207 $710,000
Q1 2018 Apr 24, 2018	SELL	$30.5 - $37.13 $20,160 - $24,542	-661 Reduced 4.25%	14,890 $569,000
Q4 2017 Jan 23, 2018	SELL	$30.9 - $39.01 $604,434 - $763,074	-19,561 Reduced 55.71%	15,551 $495,000
Q3 2017 Oct 31, 2017	BUY	$32.75 - $39.13 $1.15 Million - $1.37 Million	35,112	35,112 $1.31 Million

293

20.2M

5.2K

2.9K

Ticker LMAT
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 21,962,900
Market Cap $2.13B
Description
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...

Get notified when there are updates to the investment portfolio of Concorde Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Concorde Asset Management, LLC with notifications on news.